RecruitingUrinary IncontinenceUrinary Incontinence,Stress
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
Eligible age
22+ yrs
Accepts
Women
Locations
5 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
A prospective, single arm, non-randomized, multicenter, prospective case-series trial. The purpose of this trial is to demonstrate the safety and effectiveness of using the Adjustable Continence Therapy (ACT) to provide a clinically relevant improvement in stress urinary incontinence.
Sponsor: Uromedica
You may qualify if…
- ✓ 1. Female at least 22 years old
- ✓ 2. Diagnosed with stress urinary incontinence with primary Intrinsic Sphincter Deficiency
- ✓ 3. Provocative pad weight of greater than 11.0 grams
- ✓ 4. Candidate for surgical intervention
- ✓ 5. Negative urinalysis
- ✓ 6. Normal cystourethroscopy
- ✓ 7. Failed at least 6 months of previous treatment(s) for stress urinary incontinence (e.g., exercise regimen, electrical stimulation, surgical procedures, etc). Note: patients may have failed prior anti-incontinence procedures for SUI (e.g., suspension, sling, or urethral bulking agent)
- ✓ 8. Willing and able to sign informed consent and comply with trial follow-up requirements
You may not qualify if…
- ✕ 1. Pregnant or lactating
- ✕ 2. Life expectancy of less than 5 years
- ✕ 3. Has uncontrolled diabetes as evidenced by HbA1c over 6.5% and fasting plasma glucose over 130 mg/dL
- ✕ 4. Has auto-immune disease
- ✕ 5. Undergoing radiation therapy
- ✕ 6. Active urinary tract infection
- ✕ 7. Detrusor instability refractory to medication
- ✕ 8. Reduced bladder compliance as defined by a cystometrogram
Where it's recruiting
Source: ClinicalTrials.gov · NCT04248283 · last updated 2026-10-06